Generation Bio Co at JMP Securities Life Sciences Conference Transcript
Thank you. Thanks for joining us. Welcome back to day two of the JMP Healthcare Conference. My name is Silvan Türkcan, I'm a senior analyst with JMP covering precision medicines. It's my pleasure to host Matt Norkunas, CFO of Generation Bio. Thanks so much for joining us today.
Thanks, Silvan. It's nice to be here.
Okay. So over the past 12 months, you've been very focused on the development of your technology, and as an introduction to the people that may not -- not as familiar with your story, could you please talk about your technology and how that fits into the gene therapy space?
Sure, sure. When we think about our fit into the gene therapy space, I think there's really two angles to consider. One is the scientific angle, which I think the majority of the world is focused on. But I also think it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |